Evidence map›Paper›PMID 26437774›Full record

ArticleMalaria journal2015

The effect of local variation in malaria transmission on the prevalence of sulfadoxine-pyrimethamine resistant haplotypes and selective sweep characteristics in Malawi.

Elena Artimovich, Atupele Kapito-Tembo, Paul Pensulo, Osward Nyirenda, Sarah Brown, Sudhaunshu Joshi, Terrie E Taylor, Don Mathanga, Ananias A Escalante, Miriam K Laufer and 1 more

Abstract read
In one paragraph

Article in Malaria journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Understanding the Intransigence of Malaria in Malawi.The American journal of tropical medicine and hygiene · 2022
    Article
  3. Polymorphism of Antifolate Drug Resistance inFrontiers in cellular and infection microbiology · 2021
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Elena ArtimovichHoward Hughes Medical Institute/Center for Vaccine Development, University of Maryland School of Medicine, 685 West Baltimore Street, HSF1-480, Baltimore, MD, 21201, USA. earti001@umaryland.edu.
Atupele Kapito-TemboMalaria Alert Center, Blantyre, Malawi. atupelekapito@gmail.com.
Paul PensuloBlantyre Malaria Project, University of Malawi College of Medicine, Blantyre, Malawi. paulpensulo@gmail.com.
Osward NyirendaBlantyre Malaria Project, University of Malawi College of Medicine, Blantyre, Malawi. omnyirenda@gmail.com.
Sarah BrownUniversity of Maryland, Baltimore County, Baltimore, MD, USA. bro6@umbc.edu.
Sudhaunshu JoshiHoward Hughes Medical Institute/Center for Vaccine Development, University of Maryland School of Medicine, 685 West Baltimore Street, HSF1-480, Baltimore, MD, 21201, USA. sjoshi@medicine.umaryland.edu.
Terrie E TaylorBlantyre Malaria Project, University of Malawi College of Medicine, Blantyre, Malawi. ttmalawi@msu.edu.
Don MathangaMalaria Alert Center, Blantyre, Malawi. dmathang@mac.medcol.mw.
Ananias A EscalanteInstitute for Genomics and Evolutionary Medicine, Temple University, Philadelphia, PA, USA. ananias.escalante@asu.edu.
Miriam K LauferHoward Hughes Medical Institute/Center for Vaccine Development, University of Maryland School of Medicine, 685 West Baltimore Street, HSF1-480, Baltimore, MD, 21201, USA. mlaufer@medicine.umaryland.edu.
Shannon Takala-HarrisonHoward Hughes Medical Institute/Center for Vaccine Development, University of Maryland School of Medicine, 685 West Baltimore Street, HSF1-480, Baltimore, MD, 21201, USA. stakala@medicine.umaryland.edu.

Funding

The role of monocytes in the pathology of severe malaria.U19AI089683 · NIAID · MICHIGAN STATE UNIVERSITY · PI SEYDEL, KARL BOYNTON · 2010 to 2023
$21.4M
Clinical Trial of Chloroquine Combinations in MalawiU01AI044824 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI PLOWE, CHRISTOPHER V. · 2004 to 2009
$3.0M
Genome-wide studies to identify markers of artemisinin-resistant malariaR01AI101713 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI HARRISON, SHANNON TAKALA · 2013 to 2016
$1.8M
A Global Comparative Study of the Evolution of Antimalarial Drug ResistanceR01GM084320 · NIGMS · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI ESCALANTE, ANANIAS ALBERTO · 2008 to 2011
$1.4M
TS Prophylaxis and Drug-resistant Malaria in MalawiU01AI047858 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI PLOWE, CHRISTOPHER V. · 2005 to 2007
$1.3M
NIAID NIH HHS R01 AI101713NIAID NIH HHS R01-AI101713NIAID NIH HHS U01 AI044824NIAID NIH HHS U01-AI044824NIAID NIH HHS U01 AI047858NIAID NIH HHS U01-AI47858NIAID NIH HHS U19 AI089683NIAID NIH HHS U19-AI089683NIGMS NIH HHS R01 GM084320NIGMS NIH HHS R01-GM084320
6 · The paper itself

Abstract

backgroundPersistence of sulfadoxine-pyrimethamine (SP) resistance has been described in an urban setting in Malawi where malaria transmission is relatively low. Higher malaria transmission is associated with greater genetic diversity and more frequent genetic recombination, which could lead to a more rapid re-emergence of SP-sensitive parasites, as well as more rapid degradation of selective sweeps. In this study, the impact of local variation in malaria transmission on the prevalence of SP-resistant haplotypes and selective sweep characteristics was investigated at an urban site with low parasite prevalence and two rural sites with moderate and high parasite prevalence.

methodsSamples from three sites with different parasite prevalence were genotyped for resistance markers within pfdhfr-ts and pfdhps and at microsatellites flanking these genes. Expected heterozygosity (He) was estimated to evaluate genetic diversity.

resultsNo difference in the prevalence of highly resistant DHFR 51I/59R/108N and DHPS 437G/540E was found between sites. Small differences in He flanking pfdhfr-ts and pfdhps were seen between rural-moderate and the other sites, as well as some shared haplotypes between the rural-high and urban-low sites.

conclusionsThe results do not show an effect of local variation in malaria transmission, as inferred from parasite prevalence, on SP-resistant haplotype prevalence.

Indexed as

Drug ResistanceHaplotypesSelection, GeneticAntimalarialsDisease Transmission, InfectiousDNA, ProtozoanDrug CombinationsGenetic VariationGenotypeHumansMalariaMalawiMicrosatellite RepeatsPeptide SynthasesPlasmodiumPrevalenceAntimalarialsdihydrofolate synthetaseDNA, ProtozoanDrug Combinationsfanasil, pyrimethamine drug combinationPeptide SynthasesPyrimethamineSulfadoxineTetrahydrofolate Dehydrogenase

Identifiers

PMID26437774
PMCPMC4595317

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.